Access our complete catalogue of cancer immunotherapy clinical practice guidelines using the SITC CPG Mobile App.
This in-depth joint educational seminar, offered prior to the 2017 ASCO Annual Meeting, will enable clinical oncologists, nurses, pharmacists, and the entire medical team to effectively offer their patients additional treatment options through immunotherapy. After the seminar, attendees will be able to apply basic immunology principles to the clinical setting; effectively identify patients who may benefit from immunotherapy; confidently manage all aspects of patient care for those receiving immunotherapy; and describe emerging drugs and concepts in the field, including the value proposition of immunotherapy agents for patients and one’s clinical practice.SITC members are eligible for discounted registration! Please email firstname.lastname@example.org to obtain the discount code.
Chairs Mary L. (Nora) Disis, MD – University of Washington Mario Sznol, MD – Yale School of Medicine
12:30 – 1 p.m.
Mary L. (Nora) Disis, MD
Basic Principles of Tumor Immunology for the Non-ImmunologistJustin Paul Kline, MD – University of Chicago
Mechanisms of Immune SuppressionBrent Hanks, MD, PhD – Duke University Medical Center
General Principles of Integrating and Sequencing Immune Therapy With Chemotherapy, Radiation Therapy, or Targeted TherapiesSandra Demaria, MD – Weill Cornell Medical College
Immunotherapy in Breast and Gynecological MalignanciesChair: Leisha Emens, MD, PhD – National Cancer Institute
Immunotherapy in GI MalignanciesDung Le, MD – Sidney Kimmel Comprehensive Cancer Center
Immunotherapy for the Treatment of Head and Neck CancersTanguy Seiwert, MD – University of Chicago
7:30 – 9:10 a.m.
Chair: James Gulley, MD, PhD, FACP – National Cancer Institute
Immunotherapy for MelanomaJeffrey Weber, MD, PhD – NYU Langone Medical Center
Immunotherapy for the Treatment of non-small Cell Lung CancerNaiyer Rizvi, MD – Columbia University
Immunotherapy for the Treatment of GU CancersArjun Balar, MD – NYU Langone Medical Center
Immune Checkpoint and Cell Therapies for Hematologic MalignanciesStephen M. Ansell, MD, PhD – Mayo Clinic Cancer Center
Management of Adverse EventsChair: Mario Sznol, MD – Yale School of Medicine and Yale Cancer Center
Nursing Aspects in the Clinical Management of Patients Receiving ImmunotherapyBrianna Hoffner, NP – University of Colorado, Denver
What Is the Value of Immunotherapy in Contemporary Oncology Practice?Lowell E. Schnipper, MD, FASCO – Beth Israel Deaconess Medical Center
What Are the Most Promising New Immunotherapy Strategies?Patrick Hwu, MD – MD Anderson Cancer Center
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com